DxTerity Diagnostics


phone
+1 310.537.7857
booth
51

DxTerity Diagnostics has developed an innovative molecular test for acute radiation exposure – the REDI-Dx™ RUO* test. Using the DxTerity DxDirect™ method for direct-from-sample, multiplex gene-expression analysis and a proprietary panel of radiation-sensitive biomarkers, REDI-Dx™ is a simple, rapid, highly specific, and low-cost solution for biodosimetry and emergency management research that is superior to existing methods for estimating radiation exposure. REDI-Dx™ RUO measures the expression of a panel of inflammation and immune system biomarkers that respond to radiation in a very predictable and dose-dependent manner.